Quick Answer
Apyx Medical Corp reported Total Revenue of $52.35 million for the year ending 2023.
- Apyx Medical Corp showed an increase of +17.6% in Total Revenue from 2022 to 2023.
- This data is from Apyx Medical Corp's annual report (Form 10-K), filed with the SEC on March 21, 2024.
- XBRL data for this metric is available from 2017 to 2023 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $3.40 million | Q2 2018: $3.69 million | Q3 2018: $3.67 million | Q4 2018: $5.85 million | Q1 2019: $5.63 million | Q2 2019: $6.65 million | Q3 2019: $7.58 million | Q4 2019: $8.38 million | Q1 2020: $5.00 million | Q2 2020: $4.30 million | Q3 2020: $6.95 million | Q1 2021: $8.64 million | Q2 2021: $11.22 million | Q3 2021: $11.83 million | Q1 2022: $12.49 million | Q2 2022: $10.29 million | Q3 2022: $9.11 million | Q1 2023: $12.14 million | Q2 2023: $13.57 million | Q3 2023: $11.98 million | Q1 2024: $10.24 million | Q2 2024: $12.15 million.
- Over the full 7 years of available data (2017 to 2023), Apyx Medical Corp's Total Revenue has grown by 411.5%.
- Historical annual values: Fiscal year 2023: $52.35 million | Fiscal year 2022: $44.51 million | Fiscal year 2021: $48.52 million | Fiscal year 2020: $27.71 million | Fiscal year 2019: $28.24 million | Fiscal year 2018: $16.61 million | Fiscal year 2017: $10.23 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: